{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:19:07Z","timestamp":1790795947793,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-37798-z","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T04:03:37Z","timestamp":1769745817000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Computational strategies for unraveling insights from known inhibitors for further lead optimization: A case study on Celecoxib analogues"],"prefix":"10.1038","volume":"16","author":[{"given":"Sonam","family":"Grewal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswayan","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ujjwal","family":"Narayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polamarasetty","family":"Aparoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"37798_CR1","unstructured":"Williams, C. S., Mann, M. & Dubois, R. N. The Role of Cyclooxygenases in In\u00afammation, Cancer, and Development. http:\/\/www.stockton-press.co.uk\/onc"},{"key":"37798_CR2","doi-asserted-by":"publisher","first-page":"22152","DOI":"10.1074\/jbc.M110.119867","volume":"285","author":"AJ Vecchio","year":"2010","unstructured":"Vecchio, A. J., Simmons, D. M. & Malkowski, M. G. Structural basis of fatty acid substrate binding to cyclooxygenase-2. J. Biol. Chem. 285, 22152\u201322163 (2010).","journal-title":"J. Biol. Chem."},{"key":"37798_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/35011103","volume":"405","author":"JR Kiefer","year":"2000","unstructured":"Kiefer, J. R. et al. Structural insights into the stereochemistry of the cyclooxygenase reaction. Nature 405, 97\u2013101 (2000).","journal-title":"Nature"},{"key":"37798_CR4","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1111\/j.1582-4934.2008.00430.x","volume":"13","author":"N Zidar","year":"2009","unstructured":"Zidar, N. et al. Cyclooxygenase in normal human tissues - is COX-1 really a constitutive isoform, and COX-2 an inducible isoform? J. Cell. Mol. Med. 13, 3753\u20133763 (2009).","journal-title":"J. Cell. Mol. Med."},{"key":"37798_CR5","doi-asserted-by":"publisher","unstructured":"Rouzer, C. A., Marnett, L. J. & Cyclooxygenases Structural and functional insights. J.Lipid Res. vol. 50, (2009). https:\/\/doi.org\/10.1194\/jlr.R800042-JLR200","DOI":"10.1194\/jlr.R800042-JLR200"},{"key":"37798_CR6","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/9550","volume":"5","author":"DW Gilroy","year":"1999","unstructured":"Gilroy, D. W. et al. Inducible cyclooxygenase May have anti-inflammatory properties. Nat. Med. 5, 698\u2013701 (1999).","journal-title":"Nat. Med."},{"key":"37798_CR7","doi-asserted-by":"crossref","unstructured":"Takai, E., Tsukimoto, M., Kojima, S. & TGF-\u03b21 Downregulates COX-2 expression leading to decrease of PGE2 production in human lung cancer A549 Cells, which is involved in fibrotic response to TGF-\u03b21. PLoS One 8, e76346 (2013).","DOI":"10.1371\/journal.pone.0076346"},{"key":"37798_CR8","doi-asserted-by":"publisher","unstructured":"Rawat, C., Kukal, S., Dahiya, U. R. & Kukreti, R. Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management. J. Neuroinflammation,\u00a016, 197 (2019). https:\/\/doi.org\/10.1186\/s12974-019-1592-3","DOI":"10.1186\/s12974-019-1592-3"},{"key":"37798_CR9","doi-asserted-by":"publisher","unstructured":"Rajakariar, R., Yaqoob, M. M. & Gilroy, D. W. COX-2 in inflammation and resolution. Mol. Interv.\u00a06,\u00a0199\u2013207 (2006). https:\/\/doi.org\/10.1124\/mi.6.4.6","DOI":"10.1124\/mi.6.4.6"},{"key":"37798_CR10","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1194\/jlr.R800042-JLR200","volume":"50","author":"CA Rouzer","year":"2009","unstructured":"Rouzer, C. A. & Marnett, L. J. Cyclooxygenases: structural and functional insights. J. Lipid Res. 50, S29\u2013S34 (2009).","journal-title":"J. Lipid Res."},{"key":"37798_CR11","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3762\/bjoc.18.71","volume":"18","author":"T Mori","year":"2022","unstructured":"Mori, T. & Abe, I. Structural basis for endoperoxide-forming oxygenases. Beilstein J. Org. Chem. 18, 707\u2013721 (2022).","journal-title":"Beilstein J. Org. Chem."},{"key":"37798_CR12","doi-asserted-by":"publisher","unstructured":"Bindu, S., Mazumder, S. & Bandyopadhyay, U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochem. Pharmacol.\u00a0180,\u00a0(2020). https:\/\/doi.org\/10.1016\/j.bcp.2020.114147","DOI":"10.1016\/j.bcp.2020.114147"},{"key":"37798_CR13","doi-asserted-by":"publisher","unstructured":"Blobaum, A. L. & Marnett, L. J. Structural and functional basis of cyclooxygenase inhibition. J. Med. Chem.\u00a050, 1425\u20131441 (2007). https:\/\/doi.org\/10.1021\/jm0613166","DOI":"10.1021\/jm0613166"},{"key":"37798_CR14","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1080\/07391102.2016.1165736","volume":"35","author":"N Chaudhary","year":"2017","unstructured":"Chaudhary, N. & Aparoy, P. Deciphering the mechanism behind the varied binding activities of COXIBs through molecular dynamic Simulations, MM-PBSA binding energy calculations and per-residue energy decomposition studies. J. Biomol. Struct. Dyn. 35, 868\u2013882 (2017).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"37798_CR15","doi-asserted-by":"publisher","first-page":"e04944","DOI":"10.1016\/j.heliyon.2020.e04944","volume":"6","author":"N Chaudhary","year":"2020","unstructured":"Chaudhary, N. & Aparoy, P. Application of per-residue energy decomposition to identify the set of amino acids critical for in Silico prediction of COX-2 inhibitory activity. Heliyon 6, e04944 (2020).","journal-title":"Heliyon"},{"key":"37798_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.etp.2006.06.004","volume":"58","author":"ZA Radi","year":"2006","unstructured":"Radi, Z. A. & Khan, N. K. Effects of cyclooxygenase Inhibition on the Gastrointestinal tract. Exp. Toxicol. Pathol. 58, 163\u2013173 (2006).","journal-title":"Exp. Toxicol. Pathol."},{"key":"37798_CR17","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/nrd1225","volume":"2","author":"GA FitzGerald","year":"2003","unstructured":"FitzGerald, G. A. COX-2 and beyond: approaches to prostaglandin Inhibition in human disease. Nat. Rev. Drug Discov. 2, 879\u2013890 (2003).","journal-title":"Nat. Rev. Drug Discov"},{"key":"37798_CR18","doi-asserted-by":"publisher","unstructured":"Wallace, J. L. & Devchand, P. R. Emerging roles for cyclooxygenase-2 in gastrointestinal mucosal defense. Br. J. Pharmacol. 145, 275\u2013282 (2005). https:\/\/doi.org\/10.1038\/sj.bjp.0706201","DOI":"10.1038\/sj.bjp.0706201"},{"key":"37798_CR19","doi-asserted-by":"crossref","unstructured":"Funk, C. D. Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology. Sci. (1979). 294, 1871\u20131875 (2001).","DOI":"10.1126\/science.294.5548.1871"},{"key":"37798_CR20","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/S1471-4914(02)02383-3","volume":"8","author":"TA Samad","year":"2002","unstructured":"Samad, T. A., Sapirstein, A. & Woolf, C. J. Prostanoids and pain: unraveling mechanisms and revealing therapeutic targets. Trends Mol. Med. 8, 390\u2013396 (2002).","journal-title":"Trends Mol. Med."},{"key":"37798_CR21","doi-asserted-by":"publisher","first-page":"2S","DOI":"10.1016\/S0002-9343(97)00203-9","volume":"104","author":"JR Vane","year":"1998","unstructured":"Vane, J. R. & Botting, R. M. Mechanism of action of nonsteroidal Anti-inflammatory drugs. Am. J. Med. 104, 2S\u20138S (1998).","journal-title":"Am. J. Med."},{"key":"37798_CR22","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1021\/jm0402059","volume":"48","author":"JM Dogn\u00e9","year":"2005","unstructured":"Dogn\u00e9, J. M., Supuran, C. T. & Pratico, D. Adverse cardiovascular effects of the Coxibs. J. Med. Chem. 48, 2251\u20132257 (2005).","journal-title":"J. Med. Chem."},{"key":"37798_CR23","first-page":"324","volume":"13","author":"S Onuora","year":"2017","unstructured":"Onuora, S. Celecoxib reduces risk of ulcer bleeding. Nat. Rev. Rheumatol. 13, 324\u2013324 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"37798_CR24","doi-asserted-by":"publisher","first-page":"6271","DOI":"10.1038\/s41598-018-24548-z","volume":"8","author":"F Al-Rashed","year":"2018","unstructured":"Al-Rashed, F. et al. Celecoxib exerts protective effects in the vascular endothelium via COX-2-independent activation of AMPK-CREB-Nrf2 signalling. Sci. Rep. 8, 6271 (2018).","journal-title":"Sci. Rep."},{"key":"37798_CR25","doi-asserted-by":"publisher","unstructured":"El-Malah, A. A. et al. Selective COX-2 Inhibitors: Road from Success to Controversy and the Quest for Repurposing. Pharmaceuticals.\u00a015, (2022). https:\/\/doi.org\/10.3390\/ph15070827","DOI":"10.3390\/ph15070827"},{"key":"37798_CR26","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/ncpneuro0842","volume":"4","author":"Risk of stroke elevated","year":"2008","unstructured":"Risk of stroke elevated. By use of rofecoxib or valdecoxib. Nat. Clin. Pract. Neurol. 4, 410\u2013410 (2008).","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"37798_CR27","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/ncponc0949","volume":"4","author":"Short-term use","year":"2007","unstructured":"Short-term use. Of rofecoxib increases the risk for adverse cardiovascular events. Nat. Clin. Pract. Oncol. 4, 621\u2013621 (2007).","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"37798_CR28","doi-asserted-by":"publisher","first-page":"10252","DOI":"10.1038\/s41598-017-10928-4","volume":"7","author":"I Br\u00e6nne","year":"2017","unstructured":"Br\u00e6nne, I. et al. A genomic exploration identifies mechanisms that May explain adverse cardiovascular effects of COX-2 inhibitors. Sci. Rep. 7, 10252 (2017).","journal-title":"Sci. Rep."},{"key":"37798_CR29","unstructured":"Drugs.com. Celecoxib Dosage Guide\u2009+\u2009Max Dose, Adjustments. (2025)."},{"key":"37798_CR30","doi-asserted-by":"crossref","unstructured":"Cheng, B. R. et al. Cardiovascular safety of celecoxib in rheumatoid arthritis and osteoarthritis patients: A systematic review and metaanalysis. PLoS One 16, e0261239 (2021).","DOI":"10.1371\/journal.pone.0261239"},{"key":"37798_CR31","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","volume":"64","author":"EA Amsterdam","year":"2014","unstructured":"Amsterdam, E. A. et al. 2014 AHA\/ACC guideline for the management of patients with Non\u2013ST-Elevation acute coronary syndromes. J. Am. Coll. Cardiol. 64, e139\u2013e228 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"37798_CR32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1161\/CIRCOUTCOMES.108.805689","volume":"2","author":"WA Ray","year":"2009","unstructured":"Ray, W. A. et al. Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart disease. Circ. Cardiovasc. Qual. Outcomes. 2, 155\u2013163 (2009).","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"37798_CR33","doi-asserted-by":"publisher","first-page":"7159","DOI":"10.1016\/j.bmcl.2010.07.054","volume":"20","author":"JL Wang","year":"2010","unstructured":"Wang, J. L. et al. The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: the second clinical candidate having a shorter and favorable human half-life. Bioorg. Med. Chem. Lett. 20, 7159\u20137163 (2010).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"37798_CR34","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman, H. M. et al. The protein data bank. Nucleic Acids Res. 28, 235\u2013242 (2000).","journal-title":"Nucleic Acids Res."},{"key":"37798_CR35","unstructured":"Syst\u00e8mes, B. I. O. V. I. A. D. Biovia Discovery Studio Visualizer. Preprint at (2021)."},{"key":"37798_CR36","doi-asserted-by":"publisher","first-page":"D1180","DOI":"10.1093\/nar\/gkad1004","volume":"52","author":"B Zdrazil","year":"2024","unstructured":"Zdrazil, B. et al. The chembl database in 2023:\u00e3 drug disco v ery Platf Orm spanning multiple bioactivity data types\u00e3nd time periods. Nucleic Acids Res. 52, D1180\u2013D1192 (2024).","journal-title":"Nucleic Acids Res."},{"key":"37798_CR37","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"G Madhavi Sastry","year":"2013","unstructured":"Madhavi Sastry, G., Adzhigirey, M., Day, T., Annabhimoju, R. & Sherman, W. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J. Comput. Aided Mol. Des. 27, 221\u2013234 (2013).","journal-title":"J. Comput. Aided Mol. Des."},{"key":"37798_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle, N. M. et al. Open babel: an open chemical toolbox. J. Cheminform. 3, 33 (2011).","journal-title":"J. Cheminform"},{"key":"37798_CR39","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1002\/jcc.20945","volume":"29","author":"S Jo","year":"2008","unstructured":"Jo, S., Kim, T., Iyer, V. G. & Im, W. CHARMM-GUI: A web-based graphical user interface for CHARMM. J. Comput. Chem. 29, 1859\u20131865 (2008).","journal-title":"J. Comput. Chem."},{"key":"37798_CR40","doi-asserted-by":"crossref","unstructured":"Park, S. J., Kern, N., Brown, T., Lee, J. & Im, W. CHARMM-GUI PDB manipulator: various PDB structural modifications for biomolecular modeling and simulation. J Mol. Biol 435, 167995 (2023).","DOI":"10.1016\/j.jmb.2023.167995"},{"key":"37798_CR41","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1021\/acs.jctc.3c00044","volume":"19","author":"RC Johnston","year":"2023","unstructured":"Johnston, R. C. et al. Epik: p K a and protonation state prediction through machine learning. J. Chem. Theory Comput. 19, 2380\u20132388 (2023).","journal-title":"J. Chem. Theory Comput."},{"key":"37798_CR42","doi-asserted-by":"publisher","first-page":"6474","DOI":"10.1021\/jp003919d","volume":"105","author":"GA Kaminski","year":"2001","unstructured":"Kaminski, G. A., Friesner, R. A., Tirado-Rives, J. & Jorgensen, W. L. Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides. J. Phys. Chem. B. 105, 6474\u20136487 (2001).","journal-title":"J. Phys. Chem. B"},{"key":"37798_CR43","doi-asserted-by":"crossref","unstructured":"Jones, G. et al.\u00a0Development and validation of a genetic algorithm for flexible docking11Edited by F. E. Cohen.\u00a0J. Mol. Biol. 267, 727\u2013748 (1997).","DOI":"10.1006\/jmbi.1996.0897"},{"key":"37798_CR44","unstructured":"RDKit Open-source cheminformatics. (2025)."},{"key":"37798_CR45","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13321-018-0258-y","volume":"10","author":"H Moriwaki","year":"2018","unstructured":"Moriwaki, H., Tian, Y. S., Kawashita, N. & Takagi, T. Mordred: a molecular descriptor calculator. J. Cheminform. 10, 4 (2018).","journal-title":"J. Cheminform"},{"key":"37798_CR46","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1021\/ci7004093","volume":"48","author":"R Guha","year":"2008","unstructured":"Guha, R. & Van Drie, J. H. Structure\u2013Activity landscape index: identifying and quantifying activity cliffs. J. Chem. Inf. Model. 48, 646\u2013658 (2008).","journal-title":"J. Chem. Inf. Model."},{"key":"37798_CR47","doi-asserted-by":"crossref","unstructured":"Raymond, J. W. & Willett, P. Effectiveness of Graph-Based and Fingerprint-Based similarity measures for virtual screening of 2D chemical structure databases. Journal Computer-Aided Mol. Design 16, 59\u201371 (2002).","DOI":"10.1023\/A:1016387816342"},{"key":"37798_CR48","doi-asserted-by":"publisher","unstructured":"GROMACS Development Team. Preprint at GROMACS (2024). https:\/\/doi.org\/10.5281\/zenodo.10589697 (2024).","DOI":"10.5281\/zenodo.10589697"},{"key":"37798_CR49","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1021\/ci3003649","volume":"52","author":"K Vanommeslaeghe","year":"2012","unstructured":"Vanommeslaeghe, K., Raman, E. P. & MacKerell, A. D. Automation of the CHARMM general force field (CGenFF) II: assignment of bonded parameters and partial atomic charges. J. Chem. Inf. Model. 52, 3155\u20133168 (2012).","journal-title":"J. Chem. Inf. Model."},{"key":"37798_CR50","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1021\/ci300363c","volume":"52","author":"K Vanommeslaeghe","year":"2012","unstructured":"Vanommeslaeghe, K. & MacKerell, A. D. Automation of the CHARMM general force field (CGenFF) I: bond perception and atom typing. J. Chem. Inf. Model. 52, 3144\u20133154 (2012).","journal-title":"J. Chem. Inf. Model."},{"key":"37798_CR51","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/jcc.21367","volume":"31","author":"K Vanommeslaeghe","year":"2010","unstructured":"Vanommeslaeghe, K. et al. CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all\u2010atom additive biological force fields. J. Comput. Chem. 31, 671\u2013690 (2010).","journal-title":"J. Comput. Chem."},{"key":"37798_CR52","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926\u2013935 (1983).","journal-title":"J. Chem. Phys."},{"key":"37798_CR53","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","volume":"98","author":"T Darden","year":"1993","unstructured":"Darden, T., York, D. & Pedersen, L. Particle mesh ewald: an N \u22c5log(N) method for Ewald sums in large systems. J. Chem. Phys. 98, 10089\u201310092 (1993).","journal-title":"J. Chem. Phys."},{"key":"37798_CR54","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","volume":"18","author":"B Hess","year":"1997","unstructured":"Hess, B., Bekker, H., Berendsen, H. J. C. & Fraaije, J. G. E. M. LINCS: A linear constraint solver for molecular simulations. J. Comput. Chem. 18, 1463\u20131472 (1997).","journal-title":"J. Comput. Chem."},{"key":"37798_CR55","unstructured":"Turner, P. J. & XMGrace Version 5.1.25. Preprint at (2005)."},{"key":"37798_CR56","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1021\/ci500020m","volume":"54","author":"R Kumari","year":"2014","unstructured":"Kumari, R., Kumar, R., Lynn, A. & Open Source Drug Discovery Consortium. g_mmpbsa\u2013a GROMACS tool for high-throughput MM-PBSA calculations. J. Chem. Inf. Model. 54, 1951\u20131962 (2014).","journal-title":"J. Chem. Inf. Model."},{"key":"37798_CR57","doi-asserted-by":"publisher","unstructured":"David, C. C. & Jacobs, D. J. Principal component analysis: A method for determining the essential dynamics of proteins. in 193\u2013226 (2014). https:\/\/doi.org\/10.1007\/978-1-62703-658-0_11","DOI":"10.1007\/978-1-62703-658-0_11"},{"key":"37798_CR58","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1109\/MCSE.2007.55","volume":"9","author":"JD Hunter","year":"2007","unstructured":"Hunter, J. D. & Matplotlib A 2D graphics environment. Comput. Sci. Eng. 9, 90\u201395 (2007).","journal-title":"Comput. Sci. Eng."},{"key":"37798_CR59","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.21105\/joss.03021","volume":"6","author":"M Waskom","year":"2021","unstructured":"Waskom, M. Seaborn: statistical data visualization. J. Open. Source Softw. 6, 3021 (2021).","journal-title":"J. Open. Source Softw."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37798-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37798-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37798-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T22:02:41Z","timestamp":1771365761000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37798-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["37798"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-37798-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6720"}}